Your browser doesn't support javascript.
loading
Use of metabolic glycoengineering and pharmacological inhibitors to assess lipid and protein sialylation on cells.
Kranaster, Petra; Blum, Jonathan; Dold, Jeremias E G A; Wittmann, Valentin; Leist, Marcel.
Afiliação
  • Kranaster P; In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Constance, Germany.
  • Blum J; Konstanz Research School Chemical Biology, University of Konstanz, Constance, Germany.
  • Dold JEGA; In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Constance, Germany.
  • Wittmann V; Konstanz Research School Chemical Biology, University of Konstanz, Constance, Germany.
  • Leist M; Department of Chemistry, University of Konstanz, Constance, Germany.
J Neurochem ; 164(4): 481-498, 2023 02.
Article em En | MEDLINE | ID: mdl-36504018

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Siálicos / Ácido N-Acetilneuramínico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácidos Siálicos / Ácido N-Acetilneuramínico Idioma: En Ano de publicação: 2023 Tipo de documento: Article